BioMarin Pharmaceutical Inc
BMRN· Nasdaq
Released Aug 4, 2020, after the close
10-Q filed Aug 5, 2020, 36 days after period end · 0001048477-20-000023
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $429.49M | $387.76M | $372.85M | $317.45M |
| Net Income | -$29.18M | -$37.44M | -$16.79M | -$36.83M |
| EPS Diluted |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$0.16 |
| -$0.21 |
| -$0.09 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.